Virulence determinants in Staphylococcus aureus and their involvement in clinical syndromes

Current Infectious Disease Reports

Volumn 7, Issue 6, 2005, Pages 420-428

  Ferry, Tristan ^a   Perpoint, Thomas ^b   Vandenesch, François ^b   Etienne, Jerome ^b  

^a INSERM   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADHESIN; BINDING PROTEIN; BONE SIALOPROTEIN BINDING PROTEIN; CLUMPING FACTOR A; CLUMPING FACTOR B; COLLAGEN; COLLAGEN BINDING PROTEIN; CYTOKINE; DESMOGLEIN 1; EXFOLIATIN; FIBRONECTIN BINDING PROTEIN; HEMOLYSIN; HEMOLYSIN ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LEUKOCIDIN; LIPOTEICHOIC ACID; MEMBRANE PROTEIN; PEPTIDOGLYCAN; SCLEROPROTEIN; SIALOPROTEIN; STAPHYLOCOCCUS ENTEROTOXIN A; STAPHYLOCOCCUS ENTEROTOXIN B; STAPHYLOCOCCUS PROTEIN A; SUPERANTIGEN; TOLL LIKE RECEPTOR; TOXIC SHOCK SYNDROME TOXIN 1; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR RECEPTOR 1; UNCLASSIFIED DRUG; UNINDEXED DRUG; VIRULENCE FACTOR;

ARTHRITIS; BACTERIAL ENDOCARDITIS; BACTERIAL PNEUMONIA; BACTERIAL VIRULENCE; FULMINATING PURPURA; HUMAN; NONHUMAN; OSTEOMYELITIS; PATHOGENESIS; RASH; REVIEW; SEPTIC SHOCK; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; TOXIC EPIDERMAL NECROLYSIS; TOXIC SHOCK SYNDROME; VENTILATOR ASSOCIATED PNEUMONIA;

EID: 27944495724     PISSN: 15233847     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11908-005-0043-8     Document Type: Review

References (52)

1. Baba T, Takeuchi F, Kuroda M, et al.: Genome and virulence determinants of high virulence community-acquired MRSA. Lancet 2002, 359:1819-1827.
2. Lowy FD: Staphylococcus aureus infections. N EngI J Med 1998, 339:520-532.
3. Cheung AL, Projan SJ, Gresham H: The genomic aspect of virulence, sepsis, and resistance to killing mechanisms in Staphylococcus aureus. Curr Infect Dis Rep 2002, 4:400-410.
4. Astiz ME, Rackow EC: Septic shock. Lancet 1998, 351:1501-1505.
5. Dinges MM, Orwin PM, Schlievert PM: Exotoxins of Staphylococcus aureus. Clin Microbiol Rev 2000, 13:16-34.
6. Robbins JB, Schneerson R, Horwith G, et al.: Staphylococcus aureus types 5 and 8 capsular polysaccharide-protein conjugate vaccines. Am Heart J 2004, 147:593-598.
7. Foster TJ, Hook M: Surface protein adhesins of Staphylococcus aureus. Trends Microbiol 1998, 6:484-488.
8. Silverman GJ, Goodyear CS: A model B-cell superantigen and the immunobiology of B lymphocytes. Clin Immunol 2002, 102:117-134.
9. Gomez MI, Lee A, Reddy B, et al.: Staphylococcus aureus protein A induces airway epithelial inflammatory responses by activating TNFR1. Nat Med 2004, 10:842-848.
10. Lina G, Bohach GA, Nair SP, et al.: Standard nomenclature for the superantigens expressed by Staphylococcus. J Infect Dis 2004, 189:2334-2336.
11. Holtfreter S, Broker BM: Staphylococcal superantigens: do they play a role in sepsis? Arch Immunol Ther Exp 2005, 53:13-27.
12. Finck-Barbancon V, Duportail G, Meunier O, Colin DA: Pore formation by a two-component leukocidin from Staphylococcus aureus within the membrane of human polymorphonuclear leukocytes. Biochim Biophys Acta 1993, 1182:275-282.
13. Lina G, Piemont Y, Godail-Gamot F, et al.: Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis 1999, 29:1128-1132.
14. Cribier B, Prevost G, Couppie F, et al.: Staphylococcus aureus leukocidin: a new virulence factor in cutaneous infections? An epidemiological and experimental study. Dermatology 1992, 185:175-180.
15. Ladhani S, Joannou CL, Lochrie DP, et al.: Clinical, microbial, and biochemical aspects of the exfoliative toxins causing staphylococcal scalded-skin syndrome. Clin Microbiol Rev 1999, 12:224-242.
16. Pragman AA, Schlievert PM: Virulence regulation in Staphylococcus aureus: the need for in vivo analysis of virulence factor regulation. FEMS Immunol Med Microbiol 2004, 42:147-154.
17. Ladhani S: Understanding the mechanism of action of the exfoliative toxins of Staphylococcus aureus. FEMS Immunol Med Microbiol 2003, 39:181-189.
18. McCormick JK, Yarwood JM, Schlievert PM: Toxic shock syndrome and bacterial superantigens: an update. Annu Rev Microbiol 2001, 55:77-104.
19. Kravitz GR, Dries DJ, Peterson ML, Schlievert PM: Purpura fulminans due to Staphylococcus aureus. Clin Infect Dis 2005, 40:941-947.
20. Brun-Buisson C, Meshaka P, Pinton P, Vallet B: EPISEPSIS: a reappraisal of the epidemiology and outcome of severe sepsis in French intensive care units. Intensive Care Med 2004, 30:580-588.
21. Fournier B, Philpott DJ: Recognition of Staphylococcus aureus by the innate immune system. Clin Microbiol Rev 2005, 18:521-540.
22. Nilsson IM, Verdrengh M, Ulrich RG, et al.: Protection against Staphylococcus aureus sepsis by vaccination with recombinant staphylococcal enterotoxin A devoid of superantigenicity. J Infect Dis 1999, 180:1370-1373.
23. Ferry T, Thomas D, Genestier AL, et al.: Comparative prevalence of superantigen genes in staphylococcus aureus isolates causing sepsis with and without shock. Clin Infect Dis 2005, In press. http://www.journals.uchicago.edu/CID/journal/rapid.html. Accessed August 12, 2005.
24. Wang JE, Dahle MK, Yndestad A, et al.: Peptidoglycan of Staphylococcus aureus causes inflammation and organ injury in the rat. Crit Care Med 2004, 32:546-552.
25. Palmqvist N, Foster T, Fitzgerald JR, et al.: Fibronectin-binding proteins and fibrinogen-binding clumping factors play distinct roles in staphylococcal arthritis and systemic inflammation. J Infect Dis 2005, 191:791-8.
26. Palmqvist N, Foster T, Tarkowski A, Josefsson E: Protein A is a virulence factor in Staphylococcus aureus arthritis and septic death. Microb Pathog 2002, 33:239-249.
27. Hall AL, Domanski PJ, Patel PR, et al.: Characterization of a protective monoclonal antibody recognizing Staphylococcus aureus MSCRAMM protein clumping factor A. Infect Immun 2003, 71:6864-6870.
28. Colque-Navarro P, Palma M, Soderquist B, et al.: Antibody responses in patients with staphylococcal septicemia against two Staphylococcus aureus fibrinogen binding proteins: clumping factor and an extracellular fibrinogen binding protein. Clin Diagn Lab Immunol 2000, 7:14-20.
29. Sibelius U, Grandel U, Buerke M, et al.: Staphylococcal alpha-toxin provokes coronary vasoconstriction and loss in myocardial contractility in perfused rat hearts: role of thromboxane generation. Circulation 2000, 101:78-85.
30. Imamura T, Tanase S, Szmyd G, et al.: Induction of vascular leakage through release of bradykinin and a novel kinin by cysteine proteinases from Staphylococcus aureus. J Exp Med 2005, 201:1669-1676.
31. Yacoub A, Lindahl P, Rubin K, et al.: Purification of a bone sialoprotein-binding protein from Staphylococcus aureus. Eur J Biochem 1994, 222:919-925.
32. Elasri MO, Thomas JR, Skinner RA, et al.: Staphylococcus aureus collagen adhesin contributes to the pathogenesis of osteomyelitis. Bone 2002, 30:275-280.
33. Gemmell CG, Goutcher SC, Reid R, Sturrock RD: Role of certain virulence factors in a murine model of Staphylococcus aureus arthritis. J Med Microbiol 1997, 46:208-213.
34. Moreillon F, Que YA: Infective endocarditis. Lancet 2004, 363:139-149.
35. Moreillon P, Entenza JM, Francioli P, et al.: Role of Staphylococcus aureus coagulase and clumping factor in pathogenesis of experimental endocarditis. Infect Immun 1995, 63:4738-4743.
36. Que YA, Haeffiger JA, Piroth L, et al.: Fibrinogen and fibronectin binding cooperate for valve infection and invasion in Staphylococcus aureus experimental endocarditis. J Exp Med 2005, 201:1627-1635.
37. Vernachio J, Bayer AS, Le T, et al.: Anti-clumping factor A immunoglobulin reduces the duration of methicillin-resistant Staphylococcus aureus bacteremia in an experimental model of infective endocarditis. Antimicrob Agents Chemother 2003, 47:3400-3406.
38. Hienz SA, Schennings T, Heimdahl A, Flock JI: Collagen binding of Staphylococcus aureus is a virulence factor in experimental endocarditis. J Infect Dis 1996, 174:83-88.
39. Weidenmaier C, Peschel A, Xiong YQ, et al.: Lack of wall teichoic acids in Staphylococcus aureus leads to reduced interactions with endothelial cells and to attenuated virulence in a rabbit model of endocarditis. J Infect Dis 2005, 191:1771-1777.
40. Mongodin E, Bajolet O, Cutrona J, et al.: Fibronectin-binding proteins of Staphylococcus aureus are involved in adherence to human airway epithelium. Infect Immun 2002, 70:620-630.
41. Leemans JC, Heikens M, van Kessel KP, et al.: Lipoteichoic acid and peptidoglycan from Staphylococcus aureus synergistically induce neutrophil influx into the lungs of mice. Clin Diagn Lab Immunol 2003, 10:950-953.
42. Heyer G, Saba S, Adamo R, et al.: Staphylococcus aureus agr and sarA functions are required for invasive infection but not inflammatory responses in the lung. Infect Immun 2002, 70:127-133.
43. McElroy MC, Harty HR, Hosford GE, et al.: Alpha-toxin damages the air-blood barrier of the lung in a rat model of Staphylococcus aureus-induced pneumonia. Infect Immun 1999, 67:5541-5544.
44. Gillet Y, Issartel B, Varthems P, et al.: Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotizing pneumonia in young immunocompetent patients. Lancet 2002, 359:753-759.
45. Francis JS, Doherty MC, Lopatin U, et al.: Severe community-onset pneumonia in healthy adults caused by methicillin-resistant Staphylococcus aureus carrying the Panton-Valentine leukocidin genes. Clin Infect Dis 2005, 40:100-107.
46. de Bentzmann S, Tristan A, Etienne J, et al.: Staphylococcus aureus isolates associated with necrotizing pneumonia bind to basement membrane type I and IV collagens and laminin. J Infect Dis 2004, 190:1506-15.
47. Gauduchon V, Cozon G, Vandenesch F, et al.: Neutralization of Staphylococcus aureus Panton Valentine leukocidin by intravenous immunoglobulin in vitro. J Infect Dis 2004, 189:346-353.
48. Vandenesch F, Naimi T, Enright MC, et al.: Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis 2003, 9:978-984.
49. Oliveira DC, Tomasz A, de Lencastre H: Secrets of success of a human pathogen: molecular evolution of pandemic clones of methicillin-resistant Staphylococcus aureus. Lancet Infect Dis 2002, 2:180-189.
50. Chalumeau M, Bidet P, Lina G, et al.: Transmission of Panton-Valentine leukocidin-producing Staphylococcus aureus to a physician during resuscitation of a child. Clin Infect Dis 2005, 41:e29-30.
51. Peacock SJ, Moore CE, Justice A, et al.: Virulent combinations of adhesion and toxin genes in natural populations of Staphylococcus aureus. Infect Immun 2002, 70:4987-4996.
52. Kikuchi K: Genetic basis of neonatal methicillin-resistant Staphylococcus aureus in Japan. Pediatr Int 2003, 45:223-229.